At The LAM Foundation, we imagine a world without LAM—and we know you do too. That’s why we’re inviting you to join us in a

Get ready for a night filled with joy, community, and celebration! Join us on Saturday, September 27, for the Breath of Hope Gala, a very

Previous studies have shown that pregnancy can be risky for women with LAM, leading to faster worsening of lung function and a higher chance of

Are you living with LAM or supporting someone who is? Then LAMposium 2025 is the place to find your pearls of hope! This special event

In 2017, The LAM Foundation hosted a landmark event in Los Angeles—the Patient Benefit Conference—bringing together patients and researchers in a first of its kind

Are you passionate about science, discovery, and making a real difference in people’s lives? Then the Research Sessions at the 2025 International LAM Research Conference

Lymphangioleiomyomatosis (LAM) is a severe multisystemic and predominantly female disease that primarily affects the lung. Because of its cellular characteristics, it is classified by the

More than 800 members of the rare disease community, including 12 passionate individuals living with LAM and their families, teamed up for Rare Disease Week

The FAA has implemented a rule change regarding lithium batteries in portable oxygen concentrators (POCs), limiting the watt-hour rating of batteries to 160 Wh, with

Mutations in the TSC (tuberous sclerosis complex) genes cause the overactivation of a growth pathway called mTORC1 in lung cells, leading to a disease called

The loss of the TSC2 gene, either inherited or sporadic, can lead to pulmonary lymphangioleiomyomatosis (LAM), a rare lung disease characterized by cystic growths caused

We are pleased to inform you that the LAM Patient Research Priorities Survey (LAM-PREP), led by Dr. Marina Holz, has been a success. While Dr.